Teacher Retirement System Of Texas Macrogenics Inc Transaction History

Teacher Retirement System Of Texas

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$3.31 - $18.51 $188 - $1,055	-57 Reduced 0.55%	10,296 $44,000
Q1 2024 May 06, 2024	BUY	$9.77 - $21.47 $101,148 - $222,278	10,353 New	10,353 $152,000
Q3 2022 Nov 03, 2022	BUY	$3.01 - $5.22 $39,151 - $67,896	13,007 New	13,007 $45,000
Q2 2022 Aug 09, 2022	SELL	$2.25 - $9.99 $22,680 - $100,699	-10,080 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.12 - $16.9 $81,849 - $170,352	10,080 New	10,080 $89,000
Q1 2018 May 08, 2018	SELL	$18.89 - $32.46 $223,336 - $383,774	-11,823 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$16.19 - $20.3 $191,414 - $240,006	11,823	11,823 $225,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.